February 19, 2008 - VERSANT 440 Molecular System, an automated viral load testing system, by Siemens Healthcare, has been approved for marketing by the FDA for use with the VERSANT HCV RNA 3.0 assay for management of HCV-infected patients undergoing antiviral therapy, according to the company.
The VERSANT 440 Molecular System is designed to allow laboratories a quicker screening time.